🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

FIVE at FIVE AU: ASX lifts today, but spends most of the week with its ‘head in the sand’

Published 26/07/2024, 01:39 pm
© Reuters.  FIVE at FIVE AU: ASX lifts today, but spends most of the week with its ‘head in the sand’
AUD/USD
-
AXJO
-
GOOGL
-
GLEN
-
AXSO
-
PLL
-

The ASX is higher at around 1.30 AEST today.

The S&P/ASX200 had gained 68.40 points or 0.87% to 7,929.60, despite crossing below its 20-day moving average at time of writing. The index has lost 0.53% for the last five days, but sits 1.91% below its 52-week high.

The top-performing stocks in this index are Karoon Energy Ltd and Deep Yello Ltd, up 5.32% and 5.19% respectively.

Looking at the sectors, Utilities is the worst performed losing 0.59%. Consumer Staples was the only sector to dip, down just 0.16%. Most sectors were in the green with Materials (+1.58%), Real Estate (+1.40%), Healthcare (+1.32%) and Energy (+1.27%) the best performed.

Today’s gain bucks the pattern for most of the week.

The ASX200 finished 102 points (-1.29%) lower yesterday at 7,861 as all eleven sectors closed lower.

IG Markets analyst Tony Sycamore wrote: “While the free-falling AUD/USD has been the canary in the coal mine this week in terms of recognising the threats posed by the slowdown in China and risk sentiment more broadly, the ASX200 spent the first three days of this week with its head in the sand until yesterday's sell-off saw it close at a two-week low.”

As for small caps, the S&P/ASX Small Ordinaries (XSO) is 0.46% higher today to 3,006.70. Over the past five days, the index has lost 0.86%.

Alphabet (NASDAQ:GOOGL) earnings

This week Alphabet released another set of positive earnings.

"In Q2 2024, Alphabet delivered another earnings report with multiple beats, showcasing continued strength across its core business segments. Notably, Google Cloud achieved a significant milestone, surpassing $10 billion in quarterly revenues for the first time and generating $1 billion in operating profit, reflecting a remarkable 28.83% year-over-year growth,” wrote eToro market analyst Farhan Badami.

“Sundar Pichai, CEO of Alphabet, attributed the impressive results to the company's continued innovation and leadership in AI and cloud infrastructure. Pichai highlighted the strong performance of Google Search and the momentum in Google Cloud as key drivers of growth.

“Despite these strong financial results, Alphabet faced a setback in its strategic expansion plans. The company's bid to acquire the cybersecurity firm Wiz for $23 billion was declined, as Wiz opted to pursue an independent path towards an IPO.

The failed acquisition attempt also reflects broader challenges in the regulatory environment for big tech companies. With increasing scrutiny from regulators, large-scale mergers and acquisitions face significant hurdles.

“Alphabet's strong earnings report and continued innovation in cloud and AI position the company well for future growth. They have over $100 billion in cash, helping the company earn over a billion dollars in interest income for the quarter, proving that having substantial cash reserves and low debt in a high interest rate environment can be advantageous.

"For investors, Alphabet's solid financial health and robust revenue growth offer a positive outlook for the stock. Their continued growth in high-margin areas like cloud computing, coupled with effective cash management, positions it well for sustained long-term performance."

Five at five

Buru Energy validates Phase 1 development plan at Rafael with analysis of 3D seismic survey

Buru Energy Ltd (ASX:BRU, OTC:BRNGF) has gained increased confidence in its Phase 1 development plan for the Rafael discovery on the EP428 and EP457 licences in the Canning Basin of Western Australia after an analysis of 3D seismic survey data.

Read more

Empire Energy secures 10-year gas sales agreement with NT government to supply 25 TJ per day

Empire Energy Group Ltd (ASX:EEG, OTC:EEGUF) has locked in a binding, 10-year gas sales agreement with the Northern Territory Government to supply 25 terajoules (TJ) of gas per day from the Carpentaria Pilot Project in the Beetaloo Basin.

Read more

Cyprium Metals and Glencore (LON:GLEN) join forces to accelerate Nifty copper production

Cyprium Metals Ltd (ASX:CYM, OTC:CYPMF) and mining giant Glencore International AG have collaborated to expedite the resumption of copper production from the Nifty copper complex in Western Australia 400km southeast of Port Hedland.

Read more

Piedmont Lithium (ASX:NASDAQ:PLL, OTC:PLLTL) increases spodumene concentrate production by 23% in second quarter

Piedmont Lithium (ASX:PLL, OTC:PLLTL) Inc is nearing steady-state production at the jointly owned North American Lithium (NAL) spodumene concentrate processing plant, having shipped about 14,000 dry metric tonnes (dmt) of concentrate in the second quarter.

Read more

Horizon Minerals on track to develop Boorara project following positive ore reserve study

Horizon Minerals Ltd (ASX:HRZ) has just wrapped up its independent ore reserve study for the Boorara Gold Project, conducted by AMC Consultants. The study confirms a financially viable project, with a projected open pit mine design producing 1.24 million tonnes at a fully diluted grade of 1.24 g/t gold for a total of 49,500 ounces over an estimated 14-month mine life.

Read more

On your six

Investors are seeking the right answers to the wrong questions

Boston-based MFS investment management portfolio manager and global investment strategist Robert Almeida says: “We’re careening toward the point where fundamentals drive valuations rather than discount rates or maneuvers by policymakers. Central banks cannot fix businesses that are broken.” To combat this, investors need to ask the right questions around the terminal value of companies.

Read more

The one to watch

Tryptamine Therapeutics Begins Phase 2a Trial for IBS Treatment at MGH

Tryptamine Therapeutics Ltd (ASX:TYP) president and chief scientific officer Jim Gilligan joins Jonathan Jackson in the Proactive studio to discuss the company’s Phase 2a clinical trial at Massachusetts General Hospital (MGH) in the US, targeting the treatment of Irritable Bowel Syndrome (IBS).

Watch

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.